-
Farxiga And Jardiance Are Associated With Twofold Increased Risk For Lower Limb Amputations
November 2018: The BMJ Medical Journal Publishes New SGLT2 Diabetes Drug Observational Study (Posted by Tom Lamb at DrugInjuryWatch.com) Diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) inhibitors class are associated with…
-
CoaguChek XS PT Test Strips: Roche Devices For Blood Thinner INR Measurement – Urgent FDA Recall November 2018
More Than 1 Million Packages Of Defective Devices Used To Check INR For Warfarin May Cause Serious Injuries Or Death (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2018 Roche Diagnostics issued…
-
Amputations Side Effects: Invokana Only, Or Jardiance, Farxiga, And Other SGLT2 Inhibitors Diabetes Drugs, Too?
Increasing Degree Of Acknowledgement In Medical Literature That Toe, Foot, And Leg Amputations Are Drug-Class Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) We have been following developments in the medical realm…
-
Waiting To See Whether FDA Approves Zelnorm In 2018 After Zelnorm Was Withdrawn In 2007 For Safety Reasons
Earlier Zelnorm Recall Was Due To Potential Cardiovascular Safety Signal, With Suicidal Ideation And Behavior Being Another Issue (Posted by Tom Lamb at DrugInjuryWatch.com) On October 17, 2018 the FDA’s Gastrointestinal Drugs…
-
Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects It Now Appears, According To New Medical Evidence
Earlier Invokana Lower Limb Amputation Reports Are Being Followed By Farxiga And Jardiance Amputation Cases Now (Posted by Tom Lamb at DrugInjuryWatch.com) There is new medical evidence which suggests the hypovolemic effect…
-
Newer Diabetes Drugs Side Effect: Fournier’s Gangrene, Serious Infection Of Genital Area
FDA Mandates Label Changes With New Warnings For Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) In late August 2018 the FDA warned doctors and patients that cases…